Cargando…

Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients with Acute Low Back Pain—Randomized Controlled Trial

The aim of this study was to investigate the effect of radial extracorporeal shockwave therapy (rESWT) primarily on acute lumbar back pain (aLBP), and secondarily on physical function and quality of life. This randomized, placebo-controlled, single-blinded trial with 12-week follow-up (FU) randomize...

Descripción completa

Detalles Bibliográficos
Autores principales: Lange, Tobias, Deventer, Niklas, Gosheger, Georg, Lampe, Lukas P, Bockholt, Sebastian, Schulze Boevingloh, Albert, Schulte, Tobias L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658438/
https://www.ncbi.nlm.nih.gov/pubmed/34884271
http://dx.doi.org/10.3390/jcm10235569
_version_ 1784612732662710272
author Lange, Tobias
Deventer, Niklas
Gosheger, Georg
Lampe, Lukas P
Bockholt, Sebastian
Schulze Boevingloh, Albert
Schulte, Tobias L
author_facet Lange, Tobias
Deventer, Niklas
Gosheger, Georg
Lampe, Lukas P
Bockholt, Sebastian
Schulze Boevingloh, Albert
Schulte, Tobias L
author_sort Lange, Tobias
collection PubMed
description The aim of this study was to investigate the effect of radial extracorporeal shockwave therapy (rESWT) primarily on acute lumbar back pain (aLBP), and secondarily on physical function and quality of life. This randomized, placebo-controlled, single-blinded trial with 12-week follow-up (FU) randomized 63 patients with aLBP 1:1 into two groups receiving either rESWT (intervention) or sham rESWT (placebo) with a manipulated shockwave head not delivering any shockwaves. Both, rESWT and sham procedure were carried out eight times for four weeks. Both groups received additional analgesics and physiotherapy twice a week. Primary patient-reported outcome measure (PROM) was the visual analogue scale for aLBP (VAS-LBP). Secondary PROMs included the Oswestry disability index (ODI), Roland and Morris Disability Questionnaire (RDQ), EuroQol EQ-5D-3L, and the Beck Depression Index (BDI-II). Primary endpoint was a between-arm comparison of mean changes in VAS-LBP from baseline to final FU. At randomization, there were no differences between the two groups in relation to age and PROMs. Both groups showed significant improvement in all PROMs at final FU. VAS-LBP declined by 60.7% (p < 0.001) in the intervention and by 86.4% (p < 0.001) in the sham group. The intervention group showed significantly less pain relief after 4 and 12 weeks. The EQ-5D submodality pain showed significantly inferior results for the intervention (1.5 (0.58)) compared to the sham group (1.1 (0.33)) (p < 0.014) after eight weeks. No significant intergroup differences were observed for RDQ, ODI or BDI-II. Additional rESWT alongside conventional guideline therapy in aLBP does not have any significant effects on pain intensity, physical function, or quality of life. To the best of our knowledge, this is the first study with a high level of evidence reporting the efficacy of rESWT in aLBP treatment and will be a future basis for decision-making.
format Online
Article
Text
id pubmed-8658438
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86584382021-12-10 Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients with Acute Low Back Pain—Randomized Controlled Trial Lange, Tobias Deventer, Niklas Gosheger, Georg Lampe, Lukas P Bockholt, Sebastian Schulze Boevingloh, Albert Schulte, Tobias L J Clin Med Article The aim of this study was to investigate the effect of radial extracorporeal shockwave therapy (rESWT) primarily on acute lumbar back pain (aLBP), and secondarily on physical function and quality of life. This randomized, placebo-controlled, single-blinded trial with 12-week follow-up (FU) randomized 63 patients with aLBP 1:1 into two groups receiving either rESWT (intervention) or sham rESWT (placebo) with a manipulated shockwave head not delivering any shockwaves. Both, rESWT and sham procedure were carried out eight times for four weeks. Both groups received additional analgesics and physiotherapy twice a week. Primary patient-reported outcome measure (PROM) was the visual analogue scale for aLBP (VAS-LBP). Secondary PROMs included the Oswestry disability index (ODI), Roland and Morris Disability Questionnaire (RDQ), EuroQol EQ-5D-3L, and the Beck Depression Index (BDI-II). Primary endpoint was a between-arm comparison of mean changes in VAS-LBP from baseline to final FU. At randomization, there were no differences between the two groups in relation to age and PROMs. Both groups showed significant improvement in all PROMs at final FU. VAS-LBP declined by 60.7% (p < 0.001) in the intervention and by 86.4% (p < 0.001) in the sham group. The intervention group showed significantly less pain relief after 4 and 12 weeks. The EQ-5D submodality pain showed significantly inferior results for the intervention (1.5 (0.58)) compared to the sham group (1.1 (0.33)) (p < 0.014) after eight weeks. No significant intergroup differences were observed for RDQ, ODI or BDI-II. Additional rESWT alongside conventional guideline therapy in aLBP does not have any significant effects on pain intensity, physical function, or quality of life. To the best of our knowledge, this is the first study with a high level of evidence reporting the efficacy of rESWT in aLBP treatment and will be a future basis for decision-making. MDPI 2021-11-26 /pmc/articles/PMC8658438/ /pubmed/34884271 http://dx.doi.org/10.3390/jcm10235569 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lange, Tobias
Deventer, Niklas
Gosheger, Georg
Lampe, Lukas P
Bockholt, Sebastian
Schulze Boevingloh, Albert
Schulte, Tobias L
Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients with Acute Low Back Pain—Randomized Controlled Trial
title Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients with Acute Low Back Pain—Randomized Controlled Trial
title_full Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients with Acute Low Back Pain—Randomized Controlled Trial
title_fullStr Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients with Acute Low Back Pain—Randomized Controlled Trial
title_full_unstemmed Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients with Acute Low Back Pain—Randomized Controlled Trial
title_short Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients with Acute Low Back Pain—Randomized Controlled Trial
title_sort effectiveness of radial extracorporeal shockwave therapy in patients with acute low back pain—randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658438/
https://www.ncbi.nlm.nih.gov/pubmed/34884271
http://dx.doi.org/10.3390/jcm10235569
work_keys_str_mv AT langetobias effectivenessofradialextracorporealshockwavetherapyinpatientswithacutelowbackpainrandomizedcontrolledtrial
AT deventerniklas effectivenessofradialextracorporealshockwavetherapyinpatientswithacutelowbackpainrandomizedcontrolledtrial
AT goshegergeorg effectivenessofradialextracorporealshockwavetherapyinpatientswithacutelowbackpainrandomizedcontrolledtrial
AT lampelukasp effectivenessofradialextracorporealshockwavetherapyinpatientswithacutelowbackpainrandomizedcontrolledtrial
AT bockholtsebastian effectivenessofradialextracorporealshockwavetherapyinpatientswithacutelowbackpainrandomizedcontrolledtrial
AT schulzeboevinglohalbert effectivenessofradialextracorporealshockwavetherapyinpatientswithacutelowbackpainrandomizedcontrolledtrial
AT schultetobiasl effectivenessofradialextracorporealshockwavetherapyinpatientswithacutelowbackpainrandomizedcontrolledtrial